Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bayer Aktienges ADR (BAYRY)

Bayer Aktienges ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 31,555,490
  • Shares Outstanding, K 3,929,700
  • Annual Sales, $ 51,558 M
  • Annual Income, $ -3,183 M
  • 60-Month Beta 1.08
  • Price/Sales 0.62
  • Price/Cash Flow 2.07
  • Price/Book 0.76
Trade BAYRY with:
  • Price/Earnings ttm 5.01
  • Earnings Per Share ttm 1.62
  • Most Recent Earnings $0.25 on 08/06/24
  • Next Earnings Date 11/13/24
  • Annual Dividend & Yield 0.02 (0.27%)
  • Most Recent Dividend 0.022 on 04/29/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.17
  • Number of Estimates 1
  • High Estimate 0.17
  • Low Estimate 0.17
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.3700 +10.45%
on 09/11/24
8.1900 -0.61%
on 09/26/24
+0.4225 (+5.47%)
since 08/26/24
3-Month
6.8200 +19.35%
on 07/09/24
8.1900 -0.61%
on 09/26/24
+1.1900 (+17.12%)
since 06/26/24
52-Week
6.8200 +19.35%
on 07/09/24
12.0900 -32.67%
on 09/27/23
-3.9400 (-32.62%)
since 09/26/23

Most Recent Stories

More News
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health

The drug and biotech sector has outperformed the broader equity market this year, backed by the launch of promising new medicines, pipeline successes and an increase in merger and acquisition (M&A) activity....

BAYRY : 8.1400 (+1.37%)
AZN : 78.18 (+0.83%)
LLY : 909.32 (-1.65%)
PFE : 28.97 (+0.14%)
SNY : 57.00 (+0.62%)
Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea

Shares of Regeneron Pharmaceuticals, Inc. REGN were down 4.63% after an unfavorable ruling in its lawsuit against Amgen AMGN in the United States District Court for the Northern District of West Virginia.The...

BAYRY : 8.1400 (+1.37%)
REGN : 1,039.96 (+0.85%)
RHHBY : 40.1600 (+0.78%)
AMGN : 319.10 (+1.99%)
Johnson & Johnson Files for Bankruptcy Over Talc Lawsuits for the Third Time

Johnson & Johnson JNJ, via its subsidiary called Red River Talc, for the third time, filed for voluntary bankruptcy to resolve thousands of lawsuits related to its talc products. Red River Talc has filed...

BAYRY : 8.1400 (+1.37%)
JNJ : 161.39 (+0.49%)
LLY : 909.32 (-1.65%)
PFE : 28.97 (+0.14%)
Roche Antiviral Drug Reduces Transmission in Late-stage Study

Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza.The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, taken...

BAYRY : 8.1400 (+1.37%)
LLY : 909.32 (-1.65%)
RHHBY : 40.1600 (+0.78%)
PFE : 28.97 (+0.14%)
Novartis' Kisqali Lowers Risk of Breast Cancer Recurrence by 28%

Novartis NVS announced positive data on breast cancer drug Kisqali (ribociclib) from the late-stage study, NATALEE.This late-breaking data from this four-year post-hoc analysis was presented at the European...

NVS : 115.61 (-0.70%)
PFE : 28.97 (+0.14%)
LLY : 909.32 (-1.65%)
BAYRY : 8.1400 (+1.37%)
Bayer Reports Encouraging NSCLC Drug Data, Gets Approval for Eylea 8mg

Bayer BAYRY announced positive results from the expansion part of the ongoing early to mid-stage study on pipeline candidate BAY 2927088.BAY 2927088 is an oral, reversible tyrosine kinase inhibitor (TKI)...

REGN : 1,039.96 (+0.85%)
NVS : 115.61 (-0.70%)
LLY : 909.32 (-1.65%)
BAYRY : 8.1400 (+1.37%)
Merck Starts Late-Stage Study on Recently Acquired Ophthalmology Drug

Merck MRK announced that it started the phase IIb/III BRUNELLO study on Restoret (MK-3000), a novel investigational Wnt agonist antibody, to treat diabetic macular edema (DME).This study will evaluate...

REGN : 1,039.96 (+0.85%)
RHHBY : 40.1600 (+0.78%)
MRK : 113.09 (-1.43%)
BAYRY : 8.1400 (+1.37%)
World Bee Day Highlights Need for Agritech Innovations in Sustainable Agriculture

Issued on behalf of Bee Vectoring Technologies International Inc. VANCOUVER – USA News...

BEE.CN : 0.0100 (unch)
BEVVF : 0.0094 (-6.00%)
BAYRY : 8.1400 (+1.37%)
CTVA : 58.02 (+1.52%)
NTR : 48.66 (+3.12%)
NTR.TO : 65.57 (+3.00%)
FMC : 65.97 (+3.13%)
3 Best Agriculture ETFs to Buy for 2024

Agriculture-based exchange-traded funds (ETFs) can provide investors with portfolio diversification and a low-cost way to create a passive income stream.

DBA : 26.44 (+0.46%)
MOO : 74.73 (+2.19%)
DE : 411.47 (+1.12%)
ZTS : 194.87 (+1.74%)
BAYRY : 8.1400 (+1.37%)
NTR : 48.66 (+3.12%)
CTVA : 58.02 (+1.52%)
VEGI : 37.71 (+1.60%)
ADM : 59.37 (+2.12%)
LW : 66.50 (+2.42%)
Why Bristol Myers Squibb Stock Is Fading Today

A high-profile clinical failure by a rival is weighing on the drugmaker's shares today.

BAYRY : 8.1400 (+1.37%)
BMY : 50.12 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses....

See More

Key Turning Points

3rd Resistance Point 8.2233
2nd Resistance Point 8.2067
1st Resistance Point 8.1733
Last Price 8.1400
1st Support Level 8.1233
2nd Support Level 8.1067
3rd Support Level 8.0733

See More

52-Week High 12.0900
Fibonacci 61.8% 10.0769
Fibonacci 50% 9.4550
Fibonacci 38.2% 8.8331
Last Price 8.1400
52-Week Low 6.8200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar